Market Research Logo

MedMira Inc. (MIR) - Product Pipeline Analysis, 2016 Update

Summary

MedMira Inc. (MedMira) is a biotechnology company that offers rapid diagnostics and technology solutions. The company offers HIV, H. pylori, syphilis, multiplex, miriad rvf toolkit, and tissue and eye bank products. It offers testing products for HIV, H. Pylori and syphilis, besides combination testing solutions for HIV-1/2, hepatitis B and C, and syphilis. MedMira serves hospitals, point-of-care facilities, laboratories, governments, public health agencies and other sectors. The company distributes its products through a network of distributors and business development partners worldwide. It has manufacturing facilities in Nova Scotia, Canada and sales offices in the US. MedMira is headquartered in Halifax, Nova Scotia, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company MedMira Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


MedMira Inc. Company Snapshot
MedMira Inc. Company Overview
MedMira Inc. Pipeline Products and Clinical Trials Overview
MedMira Inc. – Pipeline Analysis Overview
Key Facts
MedMira Inc. - Major Products and Services
MedMira Inc. Pipeline Products by Development Stage
MedMira Inc. Clinical Trials by Trial Status
MedMira Inc. Pipeline Products Overview
HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3
HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3 Product Overview
HH Marker Chronic Disease Monitoring Test - Cardiac Multiplex B
HH Marker Chronic Disease Monitoring Test - Cardiac Multiplex B Product Overview
MedDuo Dual HIV Ab/Ag Test
MedDuo Dual HIV Ab/Ag Test Product Overview
MedDuo Dual Total Hepatitis B Screen Test
MedDuo Dual Total Hepatitis B Screen Test Product Overview
Multiplo HIV/HCV
Multiplo HIV/HCV Product Overview
Multiplo Rapid HBV/HIV/HCV Antibody Test
Multiplo Rapid HBV/HIV/HCV Antibody Test Product Overview
Multiplo Rapid HBV/HIV/HCV/TP Assay
Multiplo Rapid HBV/HIV/HCV/TP Assay Product Overview
Multiplo Rapid TP/Non-TP Assay
Multiplo Rapid TP/Non-TP Assay Product Overview
Multiplo TP/HIV
Multiplo TP/HIV Product Overview
Rapid Colon Cancer Test
Rapid Colon Cancer Test Product Overview
Reveal HBsAg Rapid Test
Reveal HBsAg Rapid Test Product Overview
Reveal HBsAg Rapid Test Clinical Trial
Reveal HP
Reveal HP Product Overview
Reveal TP
Reveal TP Product Overview
Reveal TSH Single Test
Reveal TSH Single Test Product Overview
MedMira Inc. - Key Competitors
MedMira Inc. - Key Employees
MedMira Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
MedMira Inc., Recent Developments
Mar 24, 2016: MedMira Reports Second Quarter Results for FY2016
Mar 03, 2016: MedMira Announces Departure of Board Director
Dec 14, 2015: MedMira Reports Fiscal First Quarter 2016 Financial Results
Dec 07, 2015: MedMira Debuts Reveal G4 Rapid HIV Test at National HIV Prevention Conference
Nov 24, 2015: MedMira Reports 2015 Fourth Quarter and Year End Financial Results
Oct 19, 2015: MedMira Receives FDA Approval for the Reveal G4 Rapid HIV-1 Antibody Test
Aug 17, 2015: MedMira Board Reinforces Biotech Bench Strength with New Appointment
Jul 20, 2015: MedMira Opens US Subsidiary in Atlanta, GA
Apr 20, 2015: MedMira Submits Reveal G4 Whole Blood Rapid HIV Test For U.S. FDA Approval
Mar 20, 2015: MedMira Reports Second Quarter Financial Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
MedMira Inc. Pipeline Products and Clinical Trials Overview
MedMira Inc. Pipeline Products by Equipment Type
MedMira Inc. Pipeline Products by Indication
MedMira Inc. Clinical Trials by Trial Status
MedMira Inc., Key Facts
MedMira Inc., Major Products and Services
MedMira Inc. Number of Pipeline Products by Development Stage
MedMira Inc. Pipeline Products Summary by Development Stage
MedMira Inc. Clinical Trials by Trial Status
MedMira Inc. Clinical Trials Summary
HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3 - Product Status
HH Marker Chronic Disease Monitoring Test - Breast Cancer CA-15-3 - Product Description
HH Marker Chronic Disease Monitoring Test - Cardiac Multiplex B - Product Status
HH Marker Chronic Disease Monitoring Test - Cardiac Multiplex B - Product Description
MedDuo Dual HIV Ab/Ag Test - Product Status
MedDuo Dual HIV Ab/Ag Test - Product Description
MedDuo Dual Total Hepatitis B Screen Test - Product Status
MedDuo Dual Total Hepatitis B Screen Test - Product Description
Multiplo HIV/HCV - Product Status
Multiplo HIV/HCV - Product Description
Multiplo Rapid HBV/HIV/HCV Antibody Test - Product Status
Multiplo Rapid HBV/HIV/HCV Antibody Test - Product Description
Multiplo Rapid HBV/HIV/HCV/TP Assay - Product Status
Multiplo Rapid HBV/HIV/HCV/TP Assay - Product Description
Multiplo Rapid TP/Non-TP Assay - Product Status
Multiplo Rapid TP/Non-TP Assay - Product Description
Multiplo TP/HIV - Product Status
Multiplo TP/HIV - Product Description
Rapid Colon Cancer Test - Product Status
Rapid Colon Cancer Test - Product Description
Reveal HBsAg Rapid Test - Product Status
Reveal HBsAg Rapid Test - Product Description
Reveal HBsAg Rapid Test - Rapid Diagnostics for HIV and Hepatitis - Multiplo HBc/HIV/HCV and Reveal HBsAg
Reveal HP - Product Status
Reveal HP - Product Description
Reveal TP - Product Status
Reveal TP - Product Description
Reveal TSH Single Test - Product Status
Reveal TSH Single Test - Product Description
MedMira Inc., Key Employees
MedMira Inc., Subsidiaries
List of Figures
MedMira Inc. Pipeline Products by Equipment Type
MedMira Inc. Pipeline Products by Development Stage
MedMira Inc. Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report